ALCAFTADINE

ALCAFTADINE was reported 907 times

ALCAFTADINE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 INFUSION SITE JOINT DISCOMFORT 1 0.2500
1 INSTILLATION SITE ABNORMAL SENSATION 1 0.1111
2 ADENOVIRAL CONJUNCTIVITIS 2 0.0690
3 CONJUNCTIVAL FOLLICLES 2 0.0625
4 SCLERAL HYPERAEMIA 36 0.0529
5 INSTILLATION SITE BURN 2 0.0465
6 METHYLENETETRAHYDROFOLATE REDUCTASE DEFICIENCY 1 0.0357
7 BLEPHARITIS ALLERGIC 1 0.0323
8 CYCLOPLEGIA 1 0.0270
9 INSTILLATION SITE INFECTION 1 0.0213
10 GIANT PAPILLARY CONJUNCTIVITIS 1 0.0200
11 CONJUNCTIVITIS VIRAL 5 0.0189
12 INTESTINAL ATONY 1 0.0164
13 CONJUNCTIVAL IRRITATION 2 0.0148
14 CONJUNCTIVAL OEDEMA 13 0.0126
15 CARNITINE DECREASED 1 0.0122
16 EYELID EROSION 1 0.0115
17 INSTILLATION SITE SWELLING 2 0.0114
18 INSTILLATION SITE ERYTHEMA 6 0.0114
19 CHEMICAL BURNS OF EYE 3 0.0108
20 EYELID EXFOLIATION 8 0.0101
21 NONINFECTIVE CONJUNCTIVITIS 1 0.0100
22 CONJUNCTIVITIS INFECTIVE 4 0.0098
23 IRIS HYPOPIGMENTATION 1 0.0093
24 DRUG-DEVICE INTERACTION 1 0.0090
25 THERMAL BURNS OF EYE 2 0.0088
26 INSTILLATION SITE PRURITUS 3 0.0080
27 ERYTHEMA OF EYELID 39 0.0072
28 INSTILLATION SITE PAIN 16 0.0065
29 CONTACT LENS INTOLERANCE 1 0.0064
30 CORNEAL INFILTRATES 2 0.0064
31 OCULAR HYPERAEMIA 299 0.0063
32 CONJUNCTIVITIS BACTERIAL 2 0.0058
33 CONJUNCTIVITIS ALLERGIC 8 0.0054
34 EYELIDS PRURITUS 16 0.0051
35 EYELID SENSORY DISORDER 1 0.0051
36 VITAMIN B6 INCREASED 1 0.0050
37 REACTION TO PRESERVATIVES 4 0.0049
38 EYELID MARGIN CRUSTING 14 0.0048
39 EYE DISCHARGE 47 0.0045
40 ALCOHOL PROBLEM 1 0.0041
41 ILLNESS ANXIETY DISORDER 1 0.0041
42 VASCULAR ACCESS SITE COMPLICATION 1 0.0040
43 BLEPHARAL PIGMENTATION 2 0.0040
44 HYPERHOMOCYSTEINAEMIA 1 0.0038
45 EYE COMPLICATION ASSOCIATED WITH DEVICE 1 0.0037
46 CONJUNCTIVAL HYPERAEMIA 13 0.0036
47 EYELID OEDEMA 42 0.0036
48 EYE INFECTION BACTERIAL 2 0.0036
49 EYELID THICKENING 1 0.0035
50 EYE BURNS 2 0.0034
51 POOR DENTAL CONDITION 1 0.0034
52 RETINAL DEPIGMENTATION 1 0.0033
53 CORNEAL LESION 1 0.0032
54 EYE ALLERGY 5 0.0032
55 DREAMY STATE 1 0.0031
56 EYE PRURITUS 103 0.0031
57 HEPATITIS ALCOHOLIC 1 0.0031
58 EYE IRRITATION 171 0.0030
59 POST CONCUSSION SYNDROME 1 0.0029
60 FOREIGN BODY SENSATION IN EYES 18 0.0028
61 KERATOCONUS 1 0.0027
62 CONJUNCTIVAL DISORDER 1 0.0026
63 PRODUCT DROPPER ISSUE 2 0.0025
64 EYELID PAIN 5 0.0025
65 LAGOPHTHALMOS 1 0.0024
66 UTERINE MASS 1 0.0024
67 PERIORBITAL PAIN 2 0.0024
68 EYE INFLAMMATION 22 0.0023
69 EYE SWELLING 84 0.0023
70 BLEPHARITIS 9 0.0022
71 SWELLING OF EYELID 14 0.0022
72 PUNCTATE KERATITIS 2 0.0022
73 ABNORMAL SENSATION IN EYE 9 0.0021
74 BLOOD CREATINE ABNORMAL 1 0.0021
75 IMMUNODEFICIENCY COMMON VARIABLE 1 0.0020
76 CONJUNCTIVITIS 38 0.0020
77 LACRIMATION INCREASED 57 0.0019
78 CORNEAL EROSION 1 0.0019
79 EYE PAIN 103 0.0018
80 ECZEMA EYELIDS 1 0.0018
81 NAIL BED BLEEDING 1 0.0018
82 LACRIMAL DISORDER 1 0.0017
83 CELLULITIS ORBITAL 1 0.0017
84 RETINAL VASCULAR DISORDER 1 0.0017
85 EYELID SKIN DRYNESS 2 0.0016
86 SPONTANEOUS PENILE ERECTION 1 0.0016
87 RECTAL FISSURE 1 0.0016
88 CHALAZION 1 0.0016
89 HYPERAEMIA 3 0.0015
90 SPUTUM ABNORMAL 1 0.0015
91 POSITRON EMISSION TOMOGRAM ABNORMAL 1 0.0014
92 BORDERLINE PERSONALITY DISORDER 1 0.0014
93 EXCESSIVE EYE BLINKING 2 0.0014
94 LOCAL REACTION 1 0.0013
95 GROWTH OF EYELASHES 1 0.0013
96 EYELID IRRITATION 3 0.0012
97 ALLERGIC SINUSITIS 1 0.0012
98 OCULAR DISCOMFORT 13 0.0012
99 EYE INFECTION 13 0.0012
100 CLEFT LIP 1 0.0011
101 SENSATION OF PRESSURE 1 0.0011
102 RHINITIS ALLERGIC 5 0.0011
103 OROPHARYNGEAL CANDIDIASIS 1 0.0011
104 ASTHENOPIA 6 0.0011
105 RETINAL EXUDATES 1 0.0011
106 PERIORBITAL SWELLING 6 0.0011
107 CONJUNCTIVAL HAEMORRHAGE 4 0.0010
108 FOREIGN BODY IN EYE 1 0.0010
109 SUSPECTED PRODUCT CONTAMINATION 1 0.0010
110 KERATITIS 3 0.0010
111 TEETH BRITTLE 1 0.0010
112 INSTILLATION SITE REACTION 1 0.0009
113 CORNEAL OEDEMA 2 0.0009
114 EYELID DISORDER 2 0.0009
115 BLADDER OPERATION 1 0.0009
116 PRURITUS ALLERGIC 1 0.0009
117 PHYSICAL PRODUCT LABEL ISSUE 1 0.0008
118 BLOOD IMMUNOGLOBULIN G INCREASED 1 0.0008
119 EYE OEDEMA 2 0.0008
120 ALLERGY TO CHEMICALS 1 0.0008
121 DACRYOSTENOSIS ACQUIRED 1 0.0008
122 RETINAL DEGENERATION 1 0.0008
123 ABDOMINAL OPERATION 1 0.0008
124 PHOTOPHOBIA 14 0.0007
125 VITAMIN B12 DEFICIENCY 3 0.0007
126 CORNEAL ABRASION 1 0.0007
127 DISCHARGE 1 0.0007
128 SUDDEN ONSET OF SLEEP 1 0.0007
129 DERMATITIS CONTACT 8 0.0007
130 TENSION HEADACHE 3 0.0007
131 SEBORRHOEIC KERATOSIS 1 0.0007
132 EYELID PTOSIS 7 0.0007
133 GENERALISED ANXIETY DISORDER 1 0.0007
134 PRECANCEROUS SKIN LESION 1 0.0007
135 COMPLEX REGIONAL PAIN SYNDROME 1 0.0007
136 BLOOD PARATHYROID HORMONE DECREASED 1 0.0007
137 HYPOSMIA 1 0.0007
138 BLEPHAROSPASM 4 0.0006
139 OPHTHALMOPLEGIA 1 0.0006
140 SCLERITIS 1 0.0006
141 SENSITIVITY OF TEETH 1 0.0006
142 PERIORBITAL OEDEMA 3 0.0006
143 DRY EYE 28 0.0006
144 ESSENTIAL HYPERTENSION 1 0.0005
145 CYSTOID MACULAR OEDEMA 1 0.0005
146 PANCREATIC CYST 1 0.0005
147 TRAUMATIC LUNG INJURY 1 0.0005
148 ADRENOCORTICAL INSUFFICIENCY ACUTE 1 0.0005
149 HYPOGEUSIA 1 0.0005
150 POLYCYTHAEMIA 1 0.0005
151 ONYCHOMADESIS 2 0.0005
152 SHOULDER OPERATION 2 0.0005
153 INFUSION SITE BRUISING 1 0.0005
154 OESOPHAGEAL VARICES HAEMORRHAGE 1 0.0005
155 EYE DISORDER 15 0.0005
156 PRODUCT LOT NUMBER ISSUE 1 0.0005
157 FEAR OF DEATH 1 0.0004
158 IMPAIRED DRIVING ABILITY 5 0.0004
159 EYE OPERATION 2 0.0004
160 SINUS PAIN 1 0.0004
161 EOSINOPHIL COUNT DECREASED 1 0.0004
162 URINE FLOW DECREASED 1 0.0004
163 LACUNAR INFARCTION 1 0.0004
164 HYPERPARATHYROIDISM SECONDARY 1 0.0004
165 VASODILATATION 1 0.0004
166 PATHOLOGICAL FRACTURE 2 0.0004
167 ILEOSTOMY 1 0.0004
168 LACTOSE INTOLERANCE 1 0.0004
169 AORTIC ARTERIOSCLEROSIS 1 0.0004
170 MEDICATION RESIDUE 1 0.0004
171 ACTINIC KERATOSIS 1 0.0004
172 RETINAL DISORDER 1 0.0004
173 MULTIPLE ALLERGIES 3 0.0004
174 NASAL DISORDER 1 0.0004
175 MIGRAINE WITH AURA 1 0.0004
176 SKIN WRINKLING 1 0.0004
177 CLUMSINESS 1 0.0004
178 TYPE IV HYPERSENSITIVITY REACTION 1 0.0004
179 MULTIPLE USE OF SINGLE-USE PRODUCT 2 0.0004
180 RESPIRATORY SYMPTOM 1 0.0004
181 SCAB 4 0.0004
182 HYPERSENSITIVITY 64 0.0003
183 PULMONARY PAIN 1 0.0003
184 INFUSION SITE REACTION 1 0.0003
185 BONE MARROW DISORDER 1 0.0003
186 EXPIRED PRODUCT ADMINISTERED 11 0.0003
187 EYE INJURY 1 0.0003
188 MYDRIASIS 4 0.0003
189 TENDON DISORDER 2 0.0003
190 INJECTION SITE INFECTION 1 0.0003
191 INFUSION SITE HAEMORRHAGE 1 0.0003
192 SKIN INJURY 1 0.0003
193 VISUAL ACUITY REDUCED 10 0.0003
194 EYE HAEMORRHAGE 4 0.0003
195 BRONCHIECTASIS 2 0.0003
196 DIABETIC RETINOPATHY 1 0.0003
197 B-CELL LYMPHOMA 1 0.0003
198 BLOOD CREATININE ABNORMAL 1 0.0003
199 HEART DISEASE CONGENITAL 1 0.0003
200 SEASONAL ALLERGY 4 0.0003
201 PRODUCT CONTAMINATION 1 0.0003
202 ASTHMATIC CRISIS 1 0.0003
203 VISION BLURRED 37 0.0003
204 PROTEIN TOTAL DECREASED 1 0.0003
205 FACE INJURY 1 0.0003
206 PARANASAL SINUS HYPERSECRETION 1 0.0003
207 GINGIVAL DISORDER 1 0.0003
208 FOOD ALLERGY 2 0.0003
209 PANIC DISORDER 1 0.0003
210 THERAPEUTIC PRODUCT EFFECT VARIABLE 1 0.0003
211 VULVOVAGINAL MYCOTIC INFECTION 1 0.0003
212 TREATMENT FAILURE 21 0.0003
213 ACTIVITIES OF DAILY LIVING IMPAIRED 5 0.0003
214 OESOPHAGEAL CANDIDIASIS 1 0.0003
215 MATERNAL EXPOSURE DURING BREAST FEEDING 1 0.0002
216 POST PROCEDURAL INFECTION 2 0.0002
217 SWELLING FACE 16 0.0002
218 PERIPHERAL VENOUS DISEASE 1 0.0002
219 GOITRE 1 0.0002
220 HYPERAESTHESIA 2 0.0002
221 APPLICATION SITE EXFOLIATION 1 0.0002
222 UPPER-AIRWAY COUGH SYNDROME 2 0.0002
223 SOCIAL PROBLEM 1 0.0002
224 SECRETION DISCHARGE 3 0.0002
225 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 17 0.0002
226 ATTENTION DEFICIT HYPERACTIVITY DISORDER 1 0.0002
227 POOR PERIPHERAL CIRCULATION 1 0.0002
228 PURULENT DISCHARGE 1 0.0002
229 PRODUCT DISPENSING ISSUE 1 0.0002
230 OCULAR ICTERUS 1 0.0002
231 DIVERTICULUM INTESTINAL 1 0.0002
232 PRODUCT TASTE ABNORMAL 3 0.0002
233 SUSPECTED OFF LABEL USE 1 0.0002
234 EAR DISORDER 1 0.0002
235 SYNOVIAL CYST 1 0.0002
236 NEPHROGENIC ANAEMIA 1 0.0002
237 TIBIA FRACTURE 1 0.0002
238 SKIN TIGHTNESS 1 0.0002
239 SPINAL COLUMN STENOSIS 1 0.0002
240 LIMB OPERATION 1 0.0002
241 HORMONE LEVEL ABNORMAL 1 0.0002
242 INCORRECT DOSAGE ADMINISTERED 1 0.0002
243 BREATH SOUNDS ABNORMAL 1 0.0002
244 CORONARY ARTERY STENOSIS 1 0.0002
245 EAR DISCOMFORT 2 0.0002
246 PRODUCT COLOUR ISSUE 1 0.0002
247 VARICOSE VEIN 1 0.0002
248 FAILURE TO THRIVE 1 0.0002
249 DERMATITIS 4 0.0002
250 CLOSTRIDIUM DIFFICILE COLITIS 2 0.0002
251 COMPRESSION FRACTURE 1 0.0002
252 BURNING SENSATION 13 0.0002
253 NONSPECIFIC REACTION 1 0.0002
254 CHOKING SENSATION 1 0.0002
255 PRODUCT PHYSICAL CONSISTENCY ISSUE 1 0.0002
256 MACULAR OEDEMA 1 0.0002
257 COLECTOMY 1 0.0002
258 PRODUCT LABEL CONFUSION 1 0.0002
259 CATARACT OPERATION 1 0.0002
260 ODYNOPHAGIA 1 0.0002
261 SQUAMOUS CELL CARCINOMA OF SKIN 1 0.0002
262 CONTRAINDICATED PRODUCT ADMINISTERED 5 0.0002
263 DERMATITIS ACNEIFORM 1 0.0002
264 MENISCUS INJURY 1 0.0002
265 PRE-EXISTING CONDITION IMPROVED 1 0.0002
266 INFUSION SITE SWELLING 1 0.0002
267 MULTIPLE INJURIES 1 0.0002
268 PHOTOPSIA 1 0.0002
269 THERAPEUTIC RESPONSE CHANGED 1 0.0002
270 INFUSION SITE PAIN 2 0.0002
271 SKIN EXFOLIATION 13 0.0002
272 DRUG SPECIFIC ANTIBODY PRESENT 1 0.0002
273 SOMNAMBULISM 1 0.0002
274 INCORRECT PRODUCT STORAGE 2 0.0002
275 POSTOPERATIVE WOUND INFECTION 1 0.0001
276 ECCHYMOSIS 1 0.0001
277 APHONIA 2 0.0001
278 MASS 2 0.0001
279 RIGHT VENTRICULAR FAILURE 1 0.0001
280 PULMONARY ARTERIAL HYPERTENSION 2 0.0001
281 PRODUCT DISPENSING ERROR 3 0.0001
282 ERYTHEMA 28 0.0001
283 SENSITIVE SKIN 1 0.0001
284 HYPOPHOSPHATAEMIA 1 0.0001
285 ARTHROPOD BITE 1 0.0001
286 SKIN HAEMORRHAGE 2 0.0001
287 SNEEZING 3 0.0001
288 PAROSMIA 1 0.0001
289 AORTIC ANEURYSM 1 0.0001
290 HAEMODYNAMIC INSTABILITY 1 0.0001
291 CONCUSSION 1 0.0001
292 BASAL CELL CARCINOMA 2 0.0001
293 PRODUCT ADMINISTRATION INTERRUPTED 1 0.0001
294 HALLUCINATION, AUDITORY 2 0.0001
295 OBSESSIVE-COMPULSIVE DISORDER 1 0.0001
296 MIOSIS 1 0.0001
297 RHINITIS 1 0.0001
298 MYASTHENIA GRAVIS 1 0.0001
299 SUBSTANCE ABUSE 1 0.0001
300 ENCEPHALOPATHY 3 0.0001
301 INFLUENZA LIKE ILLNESS 10 0.0001
302 SOMNOLENCE 24 0.0001
303 INFUSION SITE ERYTHEMA 1 0.0001
304 OSTEOARTHRITIS 5 0.0001
305 CATARACT 7 0.0001
306 VITAMIN D DECREASED 1 0.0001
307 PRODUCT CONTAINER ISSUE 1 0.0001
308 HYSTERECTOMY 1 0.0001
309 SKIN SWELLING 1 0.0001
310 NAIL DISORDER 1 0.0001
311 GROIN PAIN 1 0.0001
312 HEAD DISCOMFORT 2 0.0001
313 DRUG ERUPTION 2 0.0001
314 FEAR 3 0.0001
315 WRONG TECHNIQUE IN DRUG USAGE PROCESS 4 0.0001
316 EXOSTOSIS 1 0.0001
317 RHINORRHOEA 7 0.0001
318 HEPATIC ENCEPHALOPATHY 1 0.0001
319 NEPHROPATHY 1 0.0001
320 LACERATION 1 0.0001
321 SPUTUM DISCOLOURED 1 0.0001
322 RASH ERYTHEMATOUS 5 0.0001
323 EAR PAIN 2 0.0001
324 SINUS DISORDER 2 0.0001
325 SALIVARY HYPERSECRETION 1 0.0001
326 PREGNANCY 2 0.0001
327 EMPHYSEMA 1 0.0001
328 THERAPEUTIC RESPONSE DECREASED 6 0.0001
329 DRUG LEVEL DECREASED 1 0.0001
330 MOTOR DYSFUNCTION 1 0.0001
331 SKIN BURNING SENSATION 7 0.0001
332 LIMB DISCOMFORT 3 0.0001
333 HYPERBILIRUBINAEMIA 1 0.0001
334 WEIGHT FLUCTUATION 1 0.0001
335 KNEE ARTHROPLASTY 2 0.0001
336 DRUG ADMINISTERED AT INAPPROPRIATE SITE 1 0.0001
337 HALLUCINATION, VISUAL 2 0.0001
338 JOINT INJURY 2 0.0001
339 IRRITABLE BOWEL SYNDROME 2 0.0001
340 FAECES DISCOLOURED 2 0.0001
341 SKIN LACERATION 1 0.0001
342 RASH MACULO-PAPULAR 2 0.0001
343 HYPERTENSIVE CRISIS 1 0.0001
344 ORAL PAIN 2 0.0001
345 THERAPEUTIC PRODUCT EFFECT DECREASED 4 0.0001
346 THERAPEUTIC RESPONSE UNEXPECTED 4 0.0001
347 THROAT IRRITATION 4 0.0001
348 INTESTINAL PERFORATION 1 0.0001
349 BLOOD CALCIUM DECREASED 1 0.0001
350 NEOPLASM 1 0.0001
351 UPPER RESPIRATORY TRACT INFECTION 4 0.0001
352 MADAROSIS 1 0.0001
353 RASH MACULAR 3 0.0001
354 COVID-19 PNEUMONIA 1 0.0001
355 PRODUCT PRESCRIBING ERROR 2 0.0001
356 POLYNEUROPATHY 1 0.0001
357 WRIST FRACTURE 1 0.0001
358 ADRENAL INSUFFICIENCY 1 0.0001
359 NEURALGIA 2 0.0001
360 CARDIOMEGALY 1 0.0001
361 DYSGEUSIA 6 0.0001
362 TOOTH EXTRACTION 1 0.0001
363 INJECTION SITE DISCOLOURATION 1 0.0001
364 DERMATITIS ALLERGIC 1 0.0001
365 ROTATOR CUFF SYNDROME 1 0.0001
366 INFLAMMATION 4 0.0001
367 DIPLOPIA 2 0.0001
368 MUCOSAL INFLAMMATION 2 0.0001
369 SEDATION 2 0.0001
370 SPEECH DISORDER 4 0.0001
371 BEDRIDDEN 1 0.0001
372 ADVERSE REACTION 1 0.0001
373 PAIN OF SKIN 2 0.0001
374 MOOD ALTERED 2 0.0001
375 PERIPHERAL COLDNESS 1 0.0001
376 ABNORMAL DREAMS 2 0.0001
377 MENTAL STATUS CHANGES 2 0.0001
378 ORAL DISCOMFORT 1 0.0001
379 HUNGER 1 0.0001
380 NECK PAIN 4 0.0001
381 DYSPHONIA 4 0.0001
382 CHEST DISCOMFORT 7 0.0001
383 SURGERY 4 0.0001
384 RENAL INJURY 2 0.0001
385 IMMUNODEFICIENCY 1 0.0001
386 PRODUCT QUALITY ISSUE 9 0.0001
387 ECONOMIC PROBLEM 1 0.0001
388 CHRONIC KIDNEY DISEASE 5 0.0001
389 INSURANCE ISSUE 1 0.0001
390 PHARYNGEAL OEDEMA 1 0.0001
391 EMOTIONAL DISORDER 2 0.0001
392 OROPHARYNGEAL PAIN 6 0.0001
393 MUSCULOSKELETAL CHEST PAIN 1 0.0001
394 ANKLE FRACTURE 1 0.0001
395 TENDONITIS 1 0.0001
396 THERAPY PARTIAL RESPONDER 1 0.0001
397 SWOLLEN TONGUE 2 0.0001
398 BRAIN FOG 1 0.0001
399 RESPIRATORY TRACT CONGESTION 1 0.0001
400 OBESITY 1 0.0001
401 SCIATICA 1 0.0001
402 BACK DISORDER 1 0.0001
403 DRUG LEVEL INCREASED 1 0.0001
404 THERAPEUTIC RESPONSE SHORTENED 2 0.0001
405 FUNGAL INFECTION 2 0.0001
406 FACE OEDEMA 1 0.0001
407 SINUSITIS 6 0.0001
408 THERAPY CESSATION 3 0.0001
409 MUSCULOSKELETAL DISCOMFORT 1 0.0001
410 ORTHOSTATIC HYPOTENSION 1 0.0001
411 HEADACHE 36 0.0001
412 MUSCULOSKELETAL PAIN 3 0.0001
413 INTENTIONAL PRODUCT MISUSE 5 0.0001
414 LYMPHADENOPATHY 2 0.0001
415 DIABETES MELLITUS INADEQUATE CONTROL 1 0.0001
416 GALLBLADDER DISORDER 1 0.0001
417 TOOTHACHE 1 0.0001
418 PANIC ATTACK 2 0.0001
419 END STAGE RENAL DISEASE 1 0.0001
420 BRONCHITIS 4 0.0001
421 HEPATIC STEATOSIS 1 0.0001
422 EPISTAXIS 4 0.0001
423 BLISTER 3 0.0001
424 TUBULOINTERSTITIAL NEPHRITIS 1 0.0001
425 GASTRIC ULCER 1 0.0001
426 FEELING JITTERY 1 0.0001
427 SLEEP APNOEA SYNDROME 1 0.0001
428 LETHARGY 3 0.0001
429 PULMONARY FIBROSIS 1 0.0001
430 WHITE BLOOD CELL COUNT INCREASED 2 0.0001
431 POST PROCEDURAL COMPLICATION 1 0.0001
432 HERNIA 1 0.0001
433 CHOKING 1 0.0001
434 ORAL HERPES 1 0.0001
435 SKIN FISSURES 1 0.0001
436 DISABILITY 1 0.0001
437 UPPER LIMB FRACTURE 1 0.0001
438 IRRITABILITY 3 0.0000
439 FULL BLOOD COUNT DECREASED 1 0.0000
440 INTENTIONAL SELF-INJURY 1 0.0000
441 EXTRA DOSE ADMINISTERED 2 0.0000
442 DRUG INEFFECTIVE 65 0.0000
443 BODY TEMPERATURE INCREASED 1 0.0000
444 VISUAL IMPAIRMENT 6 0.0000
445 EXPOSURE DURING PREGNANCY 3 0.0000
446 TOOTH LOSS 1 0.0000
447 RETCHING 1 0.0000
448 RECTAL HAEMORRHAGE 2 0.0000
449 POOR QUALITY SLEEP 1 0.0000
450 COUGH 13 0.0000
451 INTERVERTEBRAL DISC PROTRUSION 1 0.0000
452 PRODUCT STORAGE ERROR 4 0.0000
453 MELAENA 1 0.0000
454 APPLICATION SITE PAIN 1 0.0000
455 RASH PAPULAR 1 0.0000
456 PANCREATITIS ACUTE 1 0.0000
457 ASTHMA 5 0.0000
458 SKIN IRRITATION 2 0.0000
459 NEPHROLITHIASIS 2 0.0000
460 SKIN DISCOLOURATION 2 0.0000
461 SEIZURE 5 0.0000
462 RENAL DISORDER 2 0.0000
463 MIGRAINE 4 0.0000
464 PRODUCTIVE COUGH 2 0.0000
465 INSOMNIA 11 0.0000
466 MENTAL IMPAIRMENT 1 0.0000
467 FIBROMYALGIA 1 0.0000
468 OFF LABEL USE 36 0.0000
469 AGEUSIA 1 0.0000
470 LEUKOPENIA 2 0.0000
471 CELLULITIS 2 0.0000
472 HAEMATEMESIS 1 0.0000
473 HEPATITIS 1 0.0000
474 ILLNESS 4 0.0000
475 SKIN ULCER 1 0.0000
476 ANHEDONIA 1 0.0000
477 DERMATITIS ATOPIC 2 0.0000
478 CHEST PAIN 7 0.0000
479 EAR INFECTION 1 0.0000
480 DRUG EFFECT DECREASED 2 0.0000
481 DRY MOUTH 3 0.0000
482 THROAT TIGHTNESS 1 0.0000
483 LIMB INJURY 1 0.0000
484 PALLOR 1 0.0000
485 DEVICE DELIVERY SYSTEM ISSUE 1 0.0000
486 ANAPHYLACTIC REACTION 2 0.0000
487 DIVERTICULITIS 1 0.0000
488 FEELING COLD 1 0.0000
489 PANCYTOPENIA 2 0.0000
490 OXYGEN SATURATION DECREASED 2 0.0000
491 INCORRECT DRUG ADMINISTRATION DURATION 1 0.0000
492 PRODUCT DOSE OMISSION IN ERROR 1 0.0000
493 RED BLOOD CELL COUNT DECREASED 1 0.0000
494 DYSSTASIA 1 0.0000
495 NASAL CONGESTION 2 0.0000
496 LABORATORY TEST ABNORMAL 1 0.0000
497 PSYCHOTIC DISORDER 1 0.0000
498 HYPOAESTHESIA 5 0.0000
499 FEELING ABNORMAL 8 0.0000
500 HYPERTENSION 7 0.0000
501 DISCOMFORT 2 0.0000
502 EPILEPSY 1 0.0000
503 FEELING HOT 2 0.0000
504 INJECTION SITE RASH 1 0.0000
505 NASOPHARYNGITIS 6 0.0000
506 FEMUR FRACTURE 1 0.0000
507 FATIGUE 25 0.0000
508 PRODUCT USE ISSUE 6 0.0000
509 HEAD INJURY 1 0.0000
510 NEUROPATHY PERIPHERAL 3 0.0000
511 CYSTITIS 1 0.0000
512 PRURITUS 12 0.0000
513 NIGHT SWEATS 1 0.0000
514 CONFUSIONAL STATE 5 0.0000
515 PNEUMONIA 10 0.0000
516 DEPRESSION 7 0.0000
517 HEART RATE INCREASED 3 0.0000
518 INFUSION RELATED REACTION 2 0.0000
519 DIZZINESS 15 0.0000
520 VIRAL INFECTION 1 0.0000
521 LIP SWELLING 1 0.0000
522 URINARY RETENTION 1 0.0000
523 URTICARIA 5 0.0000
524 RASH 13 0.0000
525 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 1 0.0000
526 CONDITION AGGRAVATED 9 0.0000
527 ANGER 1 0.0000
528 NIGHTMARE 1 0.0000
529 WEIGHT DECREASED 8 0.0000
530 HYPOXIA 1 0.0000
531 SYSTEMIC LUPUS ERYTHEMATOSUS 1 0.0000
532 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 2 0.0000
533 ANXIETY 8 0.0000
534 INCORRECT ROUTE OF DRUG ADMINISTRATION 1 0.0000
535 ELECTROCARDIOGRAM QT PROLONGED 1 0.0000
536 DRUG EFFECT INCOMPLETE 1 0.0000
537 RESTLESSNESS 1 0.0000
538 MUSCLE SPASMS 5 0.0000
539 INJECTION SITE MASS 1 0.0000
540 INFLUENZA 3 0.0000
541 ASTHENIA 10 0.0000
542 HALLUCINATION 2 0.0000
543 UNEVALUABLE EVENT 2 0.0000
544 INCORRECT DOSE ADMINISTERED 6 0.0000
545 ACUTE KIDNEY INJURY 4 0.0000
546 INJECTION SITE SWELLING 2 0.0000
547 DECREASED APPETITE 6 0.0000
548 BACK PAIN 6 0.0000
549 PALPITATIONS 3 0.0000
550 CHILLS 3 0.0000
551 ARTHRITIS 2 0.0000
552 PARAESTHESIA 4 0.0000
553 ABNORMAL BEHAVIOUR 1 0.0000
554 DRUG INTERACTION 4 0.0000
555 ABORTION SPONTANEOUS 1 0.0000
556 GASTROOESOPHAGEAL REFLUX DISEASE 2 0.0000
557 EMOTIONAL DISTRESS 3 0.0000
558 BLINDNESS 1 0.0000
559 PAIN 15 0.0000
560 LUNG NEOPLASM MALIGNANT 1 0.0000
561 DRUG DOSE OMISSION 4 0.0000
562 FALL 8 0.0000
563 NAUSEA 19 0.0000
564 POLLAKIURIA 1 0.0000
565 ROAD TRAFFIC ACCIDENT 1 0.0000
566 CEREBROVASCULAR ACCIDENT 4 0.0000
567 MYALGIA 4 0.0000
568 RENAL FAILURE 3 0.0000
569 LIVER DISORDER 1 0.0000
570 DEHYDRATION 3 0.0000
571 GASTROINTESTINAL DISORDER 2 0.0000
572 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 4 0.0000
573 NEUTROPENIA 3 0.0000
574 SUICIDAL IDEATION 2 0.0000
575 ADVERSE EVENT 2 0.0000
576 DYSPHAGIA 2 0.0000
577 DISEASE RECURRENCE 1 0.0000
578 GAIT DISTURBANCE 4 0.0000
579 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 1 0.0000
580 CONTUSION 2 0.0000
581 ATRIAL FIBRILLATION 2 0.0000
582 LUNG DISORDER 1 0.0000
583 PAIN IN EXTREMITY 6 0.0000
584 DYSPEPSIA 2 0.0000
585 AGGRESSION 1 0.0000
586 BLOOD PRESSURE INCREASED 3 0.0000
587 PERIPHERAL SWELLING 3 0.0000
588 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 1 0.0000
589 ECZEMA 1 0.0000
590 PANCREATITIS 1 0.0000
591 PLATELET COUNT DECREASED 2 0.0000
592 DISTURBANCE IN ATTENTION 1 0.0000
593 RASH PRURITIC 1 0.0000
594 OEDEMA 1 0.0000
595 CONSTIPATION 4 0.0000
596 HAEMATOCHEZIA 1 0.0000
597 TREMOR 3 0.0000
598 WEIGHT INCREASED 4 0.0000
599 MUSCULAR WEAKNESS 2 0.0000
600 URINARY TRACT INFECTION 3 0.0000
601 HERPES ZOSTER 1 0.0000
602 PRODUCT SUBSTITUTION ISSUE 1 0.0000
603 BONE PAIN 1 0.0000
604 WHEEZING 1 0.0000
605 STOMATITIS 1 0.0000
606 VERTIGO 1 0.0000
607 INJECTION SITE PAIN 5 0.0000
608 MALAISE 7 0.0000
609 LOSS OF CONSCIOUSNESS 2 0.0000
610 HYPERHIDROSIS 2 0.0000
611 DEEP VEIN THROMBOSIS 1 0.0000
612 AMNESIA 1 0.0000
613 PSORIASIS 2 0.0000
614 BLOOD PRESSURE DECREASED 1 0.0000
615 DRY SKIN 2 0.0000
616 VOMITING 7 0.0000
617 MULTIPLE SCLEROSIS RELAPSE 1 0.0000
618 ARTHRALGIA 6 0.0000
619 SLEEP DISORDER 1 0.0000
620 THERAPY INTERRUPTED 1 0.0000
621 RESPIRATORY FAILURE 1 0.0000
622 AGITATION 1 0.0000
623 THROMBOSIS 1 0.0000
624 DYSPNOEA 7 0.0000
625 CARDIAC ARREST 1 0.0000
626 PRODUCT USE IN UNAPPROVED INDICATION 3 0.0000
627 DRUG ABUSE 1 0.0000
628 GASTROINTESTINAL HAEMORRHAGE 1 0.0000
629 BALANCE DISORDER 1 0.0000
630 PYREXIA 4 0.0000
631 MUSCULOSKELETAL STIFFNESS 1 0.0000
632 COVID-19 2 0.0000
633 MATERNAL EXPOSURE DURING PREGNANCY 1 0.0000
634 ADVERSE DRUG REACTION 1 0.0000
635 NO ADVERSE EVENT 2 0.0000
636 BREAST CANCER 1 0.0000
637 CARDIAC DISORDER 1 0.0000
638 SWELLING 1 0.0000
639 BLOOD GLUCOSE INCREASED 2 0.0000
640 SYNCOPE 1 0.0000
641 HYPOTENSION 2 0.0000
642 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 2 0.0000
643 FLUSHING 1 0.0000
644 MALIGNANT NEOPLASM PROGRESSION 1 0.0000
645 ACCIDENTAL EXPOSURE TO PRODUCT 1 0.0000
646 ABDOMINAL DISTENSION 1 0.0000
647 DIARRHOEA 6 0.0000
648 SEPSIS 1 0.0000
649 ABDOMINAL PAIN 2 0.0000
650 JOINT SWELLING 1 0.0000
651 INJECTION SITE ERYTHEMA 1 0.0000
652 MEMORY IMPAIRMENT 1 0.0000
653 INFECTION 1 0.0000
654 ABDOMINAL DISCOMFORT 1 0.0000
655 MYOCARDIAL INFARCTION 1 0.0000
656 ANAEMIA 1 0.0000
657 ABDOMINAL PAIN UPPER 1 0.0000
658 OVERDOSE 1 0.0000
659 PRODUCT DOSE OMISSION ISSUE 1 0.0000
660 DEATH 2 0.0000